Search

everythinglearnresearchcommunity

for

Search:↓

Stress hormones and autoimmune reactions can cause hair loss.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Common skin conditions can greatly affect a person's mental health and social life.

Enzymes called PADIs play a key role in hair growth and loss.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

Hair cloning could solve the problem of limited donor hair in transplants.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

More effective treatments are needed for severe alopecia areata.

A woman with lupus had right heart failure due to blood clots in her lungs, but treatment improved her condition.

SLE can increase the risk of blood clots, leading to heart failure, but treatment can improve heart function.

Active treatment can help prevent scarring hair loss in SLE patients.

A young woman with severe symptoms was diagnosed with SLE and improved significantly after treatment.

Gasdermin A3 causes hair follicle stem cells to activate too early, leading to hair loss.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

The meeting concluded with optimism about increasing research and better management of vitiligo.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.